Home > Official notices > Statutory Committee inquiries  |  Search

The Pharmaceutical Journal
Vol 275 No 7371 p497
15 October 2005


Statutory Committee inquiries

The Statutory Committee will meet at the Royal Pharmaceutical Society of Great Britain, 1 Lambeth High Street, London SE1, at 9.30am on Tuesday 18 October, Wednesday 19 October and Thursday 20 October 2005 to hear the following inquiries:

Tuesday 18 October 2005
1. An inquiry into a complaint by the Council of the Society against Harold Lomax (registration number 55293) and Harold Lomax Ltd (identification number 1000832), which alleges that the erroneous endorsement and submission to the Prescription Pricing Authority of prescriptions resulting in overpayment; a dispensing error; a failure to implement procedures to minimise the risk of dispensing errors, in particular a failure to keep a record of such errors; and the supply of medicines in contravention of the requirements for labelling of a dispensed medicinal products may amount to misconduct.

Wednesday 19 October 2005
2. An inquiry into the case of Oluseyi Michael Alakiu (registration number 808322), who has been convicted of two counts of the supply of medicinal products otherwise than in accordance with a prescription given by an appropriate practitioner, contrary to Section 58 and Section 67 of the Medicines Act 1968; and being knowingly concerned in the fraudulent evasion of prohibition or restriction on importation of a Class A Controlled Drug contrary to s.170(2)(b) of the Customs and Excise Management Act 1979.

Thursday 20 October 2005
3. An inquiry into a complaint by the Council of the Society against Peter Chiu (registration number 78926), Ajay Walia (registration number 76620) and Anchor Health Ltd (identification number 1086763) which alleges that the supply of prescription only medicines without the authority of a prescription in circumstances where the conditions for a lawful supply were not satisfied, and the failure to ensure that procedures designed to minimise risks were formulated and applied, may amount to misconduct.

David Gomez
Secretary to the Statutory Committee

Back to Top


©The Pharmaceutical Journal